More on KAPA
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $0.54 |
|
|||
| Open | $0.54 | ||||
| 52 Wk High | $ | ||||
| 52 Wk Low | $ | ||||
| Day High | $0.59 | ||||
| Day Low | $0.53 | ||||
| P/E | N/A | ||||
| EPS | $ | ||||
| Volume | 112,891 | ||||
- Form 8-K Kairos Pharma, LTD. For: Oct 06
- Kairos Pharma reports positive interim data for prostate cancer drug
- Kairos Pharma Reports Positive, Statistically Significant Interim Efficacy Data from Phase 2 Trial of ENV-105 in Metastatic Prostate Cancer
- Kairos Pharma to Present and Moderate at Discovery on Target Conference in Boston, MA
- Form 8-K Kairos Pharma, LTD. For: Sep 14
- Kairos Pharma to Present at the H.C. Wainwright 28th Annual Global Investment Conference
- Form 8-K Kairos Pharma, LTD. For: Aug 21
- Kairos Pharma announces 1-for-7 reverse stock split
- Kairos Pharma Announces 1-for-7 Reverse Stock Split
- Form 10-Q Kairos Pharma, LTD. For: Jun 30
Entities mentioned with KAPA
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- IPO | View Related Stories »
- S1 | View Related Stories »
- Definitive Agreement | View Related Stories »
- H.C. Wainwright | View Related Stories »
- Rodman & Renshaw | View Related Stories »
- Show More...
